Navigation Links
Pregnant patients lose out in breast cancer treatment; a new approach is needed
Date:4/16/2008

Berlin, Germany: Pregnant breast cancer patients can be treated as closely as possible to existing guidelines for non-pregnant patients, with few ill effects, a scientist told the 6th European Breast Cancer Conference (EBCC-6) today (Wednesday 16 April).

Dr. Sibylle Loibl, Assistant Professor in Obstetrics and Gynaecology at University of Frankfurt, Germany, and a member of the German Breast Group, said that until now, evidence upon which decisions on treatment for pregnant patients could be made was limited, and that a cautious approach by doctors meant that many women did not get the best treatment for their cancer. We realised that there are hardly any data on this subject, she said, and therefore set out to collect information from patients in Germany and throughout Europe.

The German Breast Group launched a data-collection exercise in 2003. Information on 122 pregnant patients diagnosed with breast cancer between April 2003 and December 2007 was analysed for a number of factors foetal outcome four weeks after delivery, maternal outcome of pregnancy, stage and biological characteristics of the breast cancer, breast cancer therapy, sensitivity and specificity of diagnostic procedures, outcome of the child five years later, and outcome of the breast cancer five years after diagnosis.

The median gestational age at the time of diagnosis was 21 weeks, and the median age of the women 33 years. Some patients chose not to continue the pregnancy on learning of their diagnosis, but of those who did, 33.3% received surgery only, 43.2% were treated by surgery and chemotherapy, 5.4% by chemotherapy alone, and 2.7% had no treatment at all. The median time for delivery was 36 weeks, slightly earlier than that which is normal in healthy women. Although there were some health problems among the newborn babies, they were generally minor, and the foetal outcome in babies whose mothers received chemotherapy was not different to those whose
'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2

Related biology news :

1. Humans unknowing midwives for pregnant moose
2. Pregnant women at risk for unnecessary operations due to misdiagnosis of appendicitis
3. Abnormal fat metabolism underlies heart problems in diabetic patients
4. A new radiation therapy treatment developed for head and neck cancer patients
5. Device helps patients survive, regain function til transplant
6. Diet support helps chronic kidney patients
7. Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials
8. Doctors learn to control their own brains pain responses to better treat patients
9. Jefferson urologists studying regenerated neo-bladder to help spinal cord injury patients
10. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
11. New class of drug offers hope to treatment-resistant AIDS patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... May 11, 2015  Synaptics Incorporated (NASDAQ: ... solutions, today announced the appointment of Wajid ... Financial Officer, reporting to Rick Bergman , ... Chief Financial Officer, Kathleen Bayless , who ... Mr. Ali brings extensive financial management expertise ...
(Date:5/10/2015)... 11, 2015 Fingerprint Cards (FPC) has ... FPC1155 from the distributor World Peace Industrial Group (WPI), part ... Asia . Deliveries are planned to take ... by smartphone manufacturers in China . The ... revenue guidance of + 1 000 MSEK for 2015.   ...
(Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... including a researcher from Scripps Institution of Oceanography at ... tropical oceans are expanding as the oceans warm, limiting ... organisms can live or enter in search of food. ... from the Leibniz Institute of Marine Sciences (IFM-GEOMAR) in ...
... SPRING HARBOR, N.Y. (Thursday, May 1, 2008) ... field of epigenetics, the study of gene regulation through ... have brought the study of chromosomes and chromatin structure ... of Cold Spring Harbor Protocols ( www.cshprotocols.org/TOCs/toc5_08.dtl ...
... sciences in the study of biological, technological, and social ... or understand. In a May 1 Nature paper, ... networks, Santa Fe Institute (SFI) researchers Aaron Clauset, Cristopher ... can be understood as a hierarchy of modules, where ...
Cached Biology News:Oxygen depletion: A new form of ocean habitat loss 2Nature paper describes technique for extracting hierarchical structure of networks 2
(Date:6/3/2015)... 2015 Typical racks for laboratory freezers ... and depths often taking up unnecessary room in already ... Low 5 Box Freezer Racks offer a customizable ... freezer storage boxes and freezers. , “These racks ... experiments or multiple people because users can configure freezer ...
(Date:6/3/2015)... Photo-Eyewear™ ( http://www.PhotoEyewear.com ) announced that it ... http://www.PogoTec.com ) to better reflect the depth and ... it is developing and plans to commercialize. , ... provide focused resources to drive key areas associated with ... On-Track™ – There are well over 2 Billion ...
(Date:6/3/2015)... GEA's Panther™ NS3006L is a ... fully-equipped laboratory unit that is designed for continuous operation ... plants. The Panther™ NS3006L achieves the same results as ... easy installation with simple operation, quick maintenance and is ... used in many different industries, such as food, dairy, ...
(Date:6/2/2015)... DIEGO and TORONTO , ... APTO ; TSX: APS), a clinical-stage company developing new ... announced that the U.S. Food and Drug Administration (FDA) ... for the treatment of acute myeloid leukemia (AML). APTO-253, ... company,s lead product candidate in a Phase Ib clinical ...
Breaking Biology Technology:Freezer Space Can Now Be Configured Your Way with New Modular Freezer Racks 2Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 2Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 3GEA Announces the Panther™ NS3006L, a Self-Contained, Fully-Equipped Laboratory Homogenizer Well Suited for Pilot Plants 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4
... Acquisition of Shangqiu Kexin Rutin Processing Ltd. -- XI,AN, China, Sept. 9 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by ...
... Investment... -- BOZEN, SUD-TIROL, Italy, September 8, 2010 ... ... ... // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
... 8 Cord Blood America, Inc . ( ... the umbilical cord blood stem cell preservation company ... cells, a biological insurance policy, to families nationwide and ... Director, was interviewed by analyst Francis Gaskins. The interview ...
Cached Biology Technology:Huifeng Bio-Pharmaceutical Technology, Inc. Announces the Acquisition of Shangqiu Kexin Rutin Processing Ltd. 2Huifeng Bio-Pharmaceutical Technology, Inc. Announces the Acquisition of Shangqiu Kexin Rutin Processing Ltd. 3Huifeng Bio-Pharmaceutical Technology, Inc. Announces the Acquisition of Shangqiu Kexin Rutin Processing Ltd. 4Huifeng Bio-Pharmaceutical Technology, Inc. Announces the Acquisition of Shangqiu Kexin Rutin Processing Ltd. 5Huifeng Bio-Pharmaceutical Technology, Inc. Announces the Acquisition of Shangqiu Kexin Rutin Processing Ltd. 6Huifeng Bio-Pharmaceutical Technology, Inc. Announces the Acquisition of Shangqiu Kexin Rutin Processing Ltd. 7Huifeng Bio-Pharmaceutical Technology, Inc. Announces the Acquisition of Shangqiu Kexin Rutin Processing Ltd. 8Health Robotics Releases Results of First 20 i.v.STATION's Return On Investment (ROI) Studies in the USA and Canada 2Health Robotics Releases Results of First 20 i.v.STATION's Return On Investment (ROI) Studies in the USA and Canada 3Health Robotics Releases Results of First 20 i.v.STATION's Return On Investment (ROI) Studies in the USA and Canada 4Health Robotics Releases Results of First 20 i.v.STATION's Return On Investment (ROI) Studies in the USA and Canada 5Health Robotics Releases Results of First 20 i.v.STATION's Return On Investment (ROI) Studies in the USA and Canada 6Health Robotics Releases Results of First 20 i.v.STATION's Return On Investment (ROI) Studies in the USA and Canada 7Health Robotics Releases Results of First 20 i.v.STATION's Return On Investment (ROI) Studies in the USA and Canada 8Cord Blood America Says Outreach Program to OB/GYN Nurses, Insurance Case Workers, Paying Significant Dividends 2
... Rabbit polyclonal to MSY2/YBOX2 ( ... Antigen: Synthetic ... to the C-terminus of Human MSY2/YBOX2. ... is proprietary) (Peptide ...
Request Info...
Molecular Biology grade. Ideally suited for DNA and RNA separation and recovery. High gel strength. Gelling temp. 36C. Melting temp. 88C. EEO: 0.05-0.13 Resolution 0.2-40 kb; Rnase/Dnase: none detec...
... Signet offers the most comprehensive, ... requirements. We have incorporated unprecedented quality ... capabilities. This includes proven detection chemistries ... to the TechMate protocol. It also ...
Biology Products: